ID
45518
Beschreibung
Principal Investigator: Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA MeSH: Waldenstrom Macroglobulinemia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000740 Whole genome sequencing was conducted on 10 tumor/germline paired samples along with 20 additional unpaired tumor samples from patients with Waldesntrom's macroglobulinemia. Tumor lymphoplasmacytic lymphoma cells were obtained from CD19+ selected bone marrow mononuclear cells. Germline tissue was obtained from CD19 depleted peripheral blood mononuclear cells. High molecular weight DNA was then submitted for whole genome sequencing with Complete Genomics and aligned to HG19/NCBI human reference build 37.
Link
Stichworte
Versionen (1)
- 14.12.22 14.12.22 - Chiara Middel
Rechteinhaber
Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA
Hochgeladen am
14. Dezember 2022
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
dbGaP phs000740 Whole Genome Sequencing of Waldenstrom's Macroglobulinemia
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, and sequencing center variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sex, and paired germ line sample control of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
Ähnliche Modelle
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, and sequencing center variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sex, and paired germ line sample control of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
C0680251 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
C0205469 (UMLS CUI [1,4])
C0011900 (UMLS CUI [1,5])
C0024419 (UMLS CUI [1,6])
C0679228 (UMLS CUI [1,7])